(Q28325173)

https://api.crossref.org/works/10.1089/AID.1991.7.943

17 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

17 November 2022

1

T. C. Chou

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760231

17 November 2022

author name string

Q. Y. Zhu

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760231

17 November 2022

C. A. Stein

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760231

full work available at URL

17 November 2022

language of work or name

English

0 references

publication date

November 1991

0 references

http://www.liebertpub.com/doi/pdf/10.1089/aid.1991.7.943

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

AIDS Research and Human Retroviruses

17 November 2022

published in

0 references

volume

7

0 references

issue

11

0 references

page(s)

943-51

0 references

cites work

Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon

1

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.

17 November 2022

2

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Ribavirin antagonizes the effect of azidothymidine on HIV replication

17 November 2022

3

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1.

17 November 2022

4

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine

17 November 2022

5

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro

17 November 2022

6

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome

17 November 2022

7

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Dipyridamole potentiates the inhibition by 3'-azido-3'-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte-macrophages

17 November 2022

8

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

17 November 2022

9

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors

17 November 2022

10

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Synergistic Inhibition of Human Immunodeficiency Virus Replication In Vitro by Combinations of 3′-Azido-3′-Deoxythymidine and 3′-Fluoro-3′-Deoxythymidine

17 November 2022

11

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

17 November 2022

12

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Nucleoside phosphorothioates

17 November 2022

13

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Oligonucleotide analogues as potential chemotherapeutic agents

17 November 2022

14

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).

17 November 2022

15

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells

17 November 2022

16

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide

17 November 2022

17

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus

17 November 2022

19

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

17 November 2022

20

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Physicochemical properties of phosphorothioate oligodeoxynucleotides

17 November 2022

21

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands

17 November 2022

24

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus

17 November 2022

26

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element

17 November 2022

27

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Phosphoroselenoate oligodeoxynucleotides: synthesis, physico-chemical characterization, anti-sense inhibitory properties and anti-HIV activity

17 November 2022

28

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Mechanism of Interferon Action: Progress toward Its Understanding

17 November 2022

29

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro

17 November 2022

30

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.943

17 November 2022

Identifiers

0 references